These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35341945)

  • 1. Underserved groups remain underserved as eligibility criteria routinely exclude them from breast cancer trials.
    Moloney C; Shiely F
    J Clin Epidemiol; 2022 Jul; 147():132-141. PubMed ID: 35341945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollment.
    Filion M; Forget G; Brochu O; Provencher L; Desbiens C; Doyle C; Poirier B; DuRocher M; Camden S; Lemieux J
    Clin Trials; 2012 Oct; 9(5):652-9. PubMed ID: 23060323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involving American Indians and medically underserved rural populations in cancer clinical trials.
    Guadagnolo BA; Petereit DG; Helbig P; Koop D; Kussman P; Fox Dunn E; Patnaik A
    Clin Trials; 2009 Dec; 6(6):610-7. PubMed ID: 19933720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review.
    Van Spall HG; Toren A; Kiss A; Fowler RA
    JAMA; 2007 Mar; 297(11):1233-40. PubMed ID: 17374817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Broadening Trial Eligibility Criteria on the Inclusion of Patients With Brain Metastases in Cancer Clinical Trials: Time Series Analyses for 2012-2022.
    Xiao H; Vaidya R; Hershman DL; Unger JM
    J Clin Oncol; 2024 Jun; 42(16):1953-1960. PubMed ID: 38537158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the frequency of English language requirements in clinical trial eligibility criteria: A systematic analysis using ClinicalTrials.gov.
    Muthukumar AV; Morrell W; Bierer BE
    PLoS Med; 2021 Sep; 18(9):e1003758. PubMed ID: 34520467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How far is too far? Cancer prevention and clinical trial enrollment in geographically underserved patient populations.
    Ring KL; Duska LR
    Gynecol Oncol; 2024 May; 184():8-15. PubMed ID: 38271774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End-of-Life Concerns and Experiences of Living With Advanced Breast Cancer Among Medically Underserved Women.
    Adler SR; Coulter YZ; Stone K; Glaser J; Duerr M; Enochty S
    J Pain Symptom Manage; 2019 Dec; 58(6):959-967. PubMed ID: 31425820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exclusion of pregnant and lactating persons from breast cancer clinical trials: a review of active trials registered on ClinicalTrials.gov.
    Metcalfe A; Stephenson N; Cairncross ZF; Scime NV; Fidler-Benaoudia M
    Acta Obstet Gynecol Scand; 2024 Apr; 103(4):707-715. PubMed ID: 37377224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral cancer pain intervention using videoconferencing and a mobile application for medically underserved patients: Rationale, design, and methods of a prospective multisite randomized controlled trial.
    Kelleher SA; Winger JG; Fisher HM; Miller SN; Reed SD; Thorn BE; Spring B; Samsa GP; Majestic CM; Shelby RA; Sutton LM; Keefe FJ; Somers TJ
    Contemp Clin Trials; 2021 Mar; 102():106287. PubMed ID: 33497833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desiderata for Major Eligibility Criteria in Breast Cancer Clinical Trials.
    Paulson ML; Weng C
    AMIA Annu Symp Proc; 2015; 2015():2025-34. PubMed ID: 26958302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eligibility criteria and clinical trials: An FDA perspective.
    Duggal M; Sacks L; Vasisht KP
    Contemp Clin Trials; 2021 Oct; 109():106515. PubMed ID: 34329779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consolidated standards of reporting trials (CONSORT) and the completeness of reporting of randomised controlled trials (RCTs) published in medical journals.
    Turner L; Shamseer L; Altman DG; Weeks L; Peters J; Kober T; Dias S; Schulz KF; Plint AC; Moher D
    Cochrane Database Syst Rev; 2012 Nov; 11(11):MR000030. PubMed ID: 23152285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex Disparities in Enrollment in Recent Randomized Clinical Trials of Acute Stroke: A Meta-analysis.
    Strong B; Pudar J; Thrift AG; Howard VJ; Hussain M; Carcel C; de Los Campos G; Reeves MJ
    JAMA Neurol; 2021 Jun; 78(6):666-677. PubMed ID: 33900363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to inclusion of older adults in randomised controlled clinical trials on Non-Hodgkin's lymphoma: a systematic review.
    Bellera C; Praud D; Petit-Monéger A; McKelvie-Sebileau P; Soubeyran P; Mathoulin-Pélissier S
    Cancer Treat Rev; 2013 Nov; 39(7):812-7. PubMed ID: 23473865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eligibility criteria in clinical trials in breast cancer: a cohort study.
    Szlezinger K; Pogoda K; Jagiełło-Gruszfeld A; Kłosowska D; Górski A; Borysowski J
    BMC Med; 2023 Jul; 21(1):240. PubMed ID: 37400830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of eligibility and recruitment in breast cancer clinical trials.
    Lemieux J; Forget G; Brochu O; Provencher L; Cantin G; Desbiens C; Doyle C; Poirier B; Camden S; Durocher M
    Breast; 2014 Aug; 23(4):385-92. PubMed ID: 24679829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer prevention and control among the medically underserved.
    Kerner JF
    Breast Cancer Res Treat; 1996; 40(1):1-9. PubMed ID: 8888148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.